Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells

Eighty % of ovarian cancer patients diagnosed at an advanced-stage have complete remission after initial surgery and chemotherapy. However, most patients die within <5 years due to episodes of recurrences resulting from the growth of residual chemoresistant cells. In an effort to identify mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Nuzhat, Greening, David, Samardzija, Chantel, Escalona, Ruth M., Chen, Maoshan, Findlay, Jock K., Kannourakis, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965858/
https://www.ncbi.nlm.nih.gov/pubmed/27470985
http://dx.doi.org/10.1038/srep30061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965858/
https://www.ncbi.nlm.nih.gov/pubmed/27470985
http://dx.doi.org/10.1038/srep30061

Ejemplares similares